Anmol Healthcare Laboratory Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
as on 09-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 09-07-2024
- Company Age 5 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.64 Cr
as on 09-07-2024
- Revenue 123.90%
(FY 2022)
- Profit 141.37%
(FY 2022)
- Ebitda 690.48%
(FY 2022)
- Net Worth 22.69%
(FY 2022)
- Total Assets 10.79%
(FY 2022)
About Anmol Healthcare Laboratory
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹2.64 Cr.
Bhavanaben Chopada, Vikita Doshi, Hetalben Kapuriya, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24239GJ2019PTC111446
- Company No.
111446
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surendra Nagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anmol Healthcare Laboratory?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavanaben Chopada  | Additional Director | 21-Feb-2020 | Current |
| Vikita Doshi | Additional Director | 14-Aug-2020 | Current |
| Hetalben Kapuriya | Additional Director | 14-Aug-2020 | Current |
| Hiren Rajvir | Additional Director | 14-Aug-2020 | Current |
| Bhavenkumar Patel | Additional Director | 21-Feb-2020 | Current |
| Dhaval Patel | Director | 16-Dec-2019 | Current |
Financial Performance of Anmol Healthcare Laboratory.
Anmol Healthcare Laboratory Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 123.9% increase. The company also saw a substantial improvement in profitability, with a 141.37% increase in profit. The company's net worth Soared by an impressive increase of 22.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anmol Healthcare Laboratory?
In 2022, Anmol Healthcare Laboratory had a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Jun 2020 | ₹2.64 Cr | Open |
How Many Employees Work at Anmol Healthcare Laboratory?
Anmol Healthcare Laboratory has a workforce of 13 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anmol Healthcare Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anmol Healthcare Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
